Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Probable obsessive-compulsive disorder among youth in Singapore: Prevalence, sociodemographic correlates, and the association with psychological distress, harmful alcohol use and functional impairment.

Comprehensive psychiatry·2026

Same author

Cell-free culture supernatant of Lactobacillus curvatus Wikim38 inhibits RANKL-induced osteoclast differentiation and ameliorates bone loss in ovariectomized mice.

Letters in applied microbiology·2021

Same author

Recovery of <i>Lactobacillus casei</i> strain Shirota (LcS) from faeces of healthy Singapore adults after intake of fermented milk.

Beneficial microbes·2020

Same author

Heterogeneous health profiles and healthcare utilization of the middle-aged and elderly with multiple health insurance schemes in China.

Public health·2019

Same author

Tea for Alzheimer Prevention.

The journal of prevention of Alzheimer's disease·2017

Same author

Depressive Symptoms Increase the Risk of Mild Neurocognitive Disorders among Elderly Chinese.

The journal of nutrition, health & aging·2017

Search research articles

Related Experiment Video

Updated: Apr 29, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Molecular imaging for depressive disorders.

T-S Lee¹, S Y Quek², K R R Krishnan²

¹From the Duke-National University of Singapore Graduate Medical School, Singapore. tihshih.lee@duke-nus.edu.sg.

AJNR. American Journal of Neuroradiology

|May 17, 2014

Summary

This summary is machine-generated.

Molecular imaging, using MR spectroscopy and PET, explores depression's molecular basis. While MR spectroscopy shows neurotransmitter roles, PET has limited success in correlating imaging with depression severity or treatment outcomes.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Related Experiment Videos

Last Updated: Apr 29, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Area of Science:

Neuroscience
Biochemistry
Medical Imaging

Background:

Molecular imaging visualizes biological processes at molecular and cellular levels.
Techniques like MR spectroscopy and Positron Emission Tomography (PET) are used to study depression's molecular pathophysiology.
MR spectroscopy assesses brain metabolites noninvasively; PET uses radioligands to target specific molecules.

Purpose of the Study:

To explore the molecular pathophysiology of depression using molecular imaging.
To assess the effectiveness of molecular imaging techniques in evaluating treatment responses in depression.

Main Methods:

Utilized Magnetic Resonance (MR) spectroscopy to measure brain biochemical metabolite levels.
Employed Positron Emission Tomography (PET) with radioligands to assess target molecule binding potential.

Main Results:

MR spectroscopy findings indicate a role for glutamate/glutamine and gamma-aminobutyric acid in depression.
PET studies generally did not correlate radioligand binding with depression severity or treatment response.
PET shows potential in differentiating treatment responders from nonresponders.

Conclusions:

Molecular imaging techniques offer insights into depression's neurochemical underpinnings.
Challenges remain due to depression's heterogeneity and the limited scope of current MR spectroscopy and PET analyses.
Further advancements are needed for comprehensive neurochemical evaluation in depression.